MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer

Concomitant administration of radiotherapy with cisplatin or radiotherapy with cetuximab appear to be the treatment of choice for patients with locally advanced head and neck cancer. In the present retrospective analysis, we investigated the predictive role of several biomarkers in an unselected coh...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Fountzilas, George, Kalogera-Fountzila, Anna, Lambaki, Sophia, Wirtz, Ralph M., Nikolaou, Angelos, Karayannopoulou, Georgia, Bobos, Mattheos, Kotoula, Vassiliki, Murray, Samuel, Lambropoulos, Alexandros, Aravantinos, Gerasimos, Markou, Konstantinos, Athanassiou, Eleni, Misailidou, Despina, Kalogeras, Konstantine T., Skarlos, Demosthenis
Format: Artigo
Jezik:Inglês
Izdano: Hindawi Publishing Corporation 2009
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2801452/
https://ncbi.nlm.nih.gov/pubmed/20066159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2009/305908
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items